Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Nitisinone tablets bulk supplier for pharma manufacturers

Nitisinone Tablets 2 mg and 5 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 2 mg and 5 mg

Reference Brands: Orfadin®

Category: Orphan Drugs

Nitisinone inhibits the enzyme 4-hydroxyphenylpyruvate dioxygenase, reducing the production of toxic metabolites in hereditary tyrosinemia type 1 (HT-1). Benefits include preventing liver and kidney damage, decreasing hypersensitivity reactions, and improving survival rates in HT-1 patients by controlling disease progression.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Nitisinone inhibits the enzyme 4-hydroxyphenylpyruvate dioxygenase, reducing the production of toxic metabolites in hereditary tyrosinemia type 1 (HT-1). Benefits include preventing liver and kidney damage, decreasing hypersensitivity reactions, and improving survival rates in HT-1 patients by controlling disease progression.

Nitisinone Tablets — third party manufacturing & bulk supply

Nitisinone Tablets 2 mg and 5 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Indicative minimum order quantity

Nitisinone Tablets is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Nitisinone Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Nitisinone Tablets →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Nitisinone tablets is listed as Tablets in 2 mg and 5 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Nitisinone tablets is referenced against Orfadin®. Reference brands are shown for identification only and remain the property of their respective trademark owners.

Nitisinone tablets is catalogued under Orphan Drugs on PharmaTradz. Related products within the same category are listed at the foot of this page.

Submit an RFQ stating your destination market, required quantity and whether you need stock supply, third party manufacturing or dossier licensing. Matched suppliers respond with pricing, MOQ and lead times.

Related Products

Palovarotene

Strength:
5 mg, 10 mg

Form: Capsules

Reference Brands: Sohonos (USA/EU)

View Details
Pasireotide Diaspartate

Strength:
0.3 mg/mL, 0.6 mg/mL, 1.2 mg/mL, 10 mg, 20 mg, 30 mg

Form: Injection

Reference Brands: Signifor (USA/EU)

View Details
Sepiapterin

Strength:
1000 mg, 250 mg

Form: Tablets / oral powder

Reference Brands: Sephience (USA/EU)

View Details
Glycerol Phenylbutyrate

Strength:
1.1 g/mL

Form: Oral Solution

Reference Brands: Ravicti (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.